AksharChem (India) Balance Sheet Health
Financial Health criteria checks 3/6
AksharChem (India) has a total shareholder equity of ₹2.6B and total debt of ₹682.4M, which brings its debt-to-equity ratio to 26.1%. Its total assets and total liabilities are ₹4.0B and ₹1.4B respectively. AksharChem (India)'s EBIT is ₹37.1M making its interest coverage ratio 1. It has cash and short-term investments of ₹32.4M.
Key information
26.1%
Debt to equity ratio
₹682.42m
Debt
| Interest coverage ratio | 1x |
| Cash | ₹32.41m |
| Equity | ₹2.61b |
| Total liabilities | ₹1.37b |
| Total assets | ₹3.98b |
Recent financial health updates
AksharChem (India) (NSE:AKSHARCHEM) Is Carrying A Fair Bit Of Debt
Aug 04
Here's Why AksharChem (India) (NSE:AKSHARCHEM) Can Afford Some Debt
Dec 28Is AksharChem (India) (NSE:AKSHARCHEM) Using Too Much Debt?
Aug 16AksharChem (India) (NSE:AKSHARCHEM) Takes On Some Risk With Its Use Of Debt
Sep 02AksharChem (India) (NSE:AKSHARCHEM) Has A Pretty Healthy Balance Sheet
May 25Here's Why AksharChem (India) (NSE:AKSHARCHEM) Can Manage Its Debt Responsibly
Jan 24Recent updates
AksharChem (India) (NSE:AKSHARCHEM) Is Paying Out A Dividend Of ₹0.50
Sep 12AksharChem (India) (NSE:AKSHARCHEM) Is Carrying A Fair Bit Of Debt
Aug 04Revenues Working Against AksharChem (India) Limited's (NSE:AKSHARCHEM) Share Price Following 29% Dive
Mar 29Here's Why AksharChem (India) (NSE:AKSHARCHEM) Can Afford Some Debt
Dec 28AksharChem (India) (NSE:AKSHARCHEM) Has Announced A Dividend Of ₹0.50
Sep 08Is AksharChem (India) (NSE:AKSHARCHEM) Using Too Much Debt?
Aug 16AksharChem (India) (NSE:AKSHARCHEM) Takes On Some Risk With Its Use Of Debt
Sep 02AksharChem (India) (NSE:AKSHARCHEM) Has A Pretty Healthy Balance Sheet
May 25AksharChem (India)'s (NSE:AKSHARCHEM) Returns On Capital Not Reflecting Well On The Business
Feb 24Here's Why AksharChem (India) (NSE:AKSHARCHEM) Can Manage Its Debt Responsibly
Jan 24AksharChem (India)'s (NSE:AKSHARCHEM) Returns On Capital Not Reflecting Well On The Business
Nov 03AksharChem (India) (NSE:AKSHARCHEM) Could Be Struggling To Allocate Capital
Jul 09We Think AksharChem (India) (NSE:AKSHARCHEM) Is Taking Some Risk With Its Debt
Jun 12Will AksharChem (India) (NSE:AKSHARCHEM) Multiply In Value Going Forward?
Feb 13AksharChem (India) Limited's (NSE:AKSHARCHEM) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 09Three Things You Should Check Before Buying AksharChem (India) Limited (NSE:AKSHARCHEM) For Its Dividend
Nov 26The Trends At AksharChem (India) (NSE:AKSHARCHEM) That You Should Know About
Oct 22Earnings Not Telling The Story For AksharChem (India) Limited (NSE:AKSHARCHEM)
Sep 17
These 4 Measures Indicate That AksharChem (India) (NSE:AKSHARCHEM) Is Using Debt Extensively
Aug 22Here's What To Make Of AksharChem (India)'s (NSE:AKSHARCHEM) Returns On Capital
Jun 30Financial Position Analysis
Short Term Liabilities: AKSHARCHEM's short term assets (₹1.3B) exceed its short term liabilities (₹971.8M).
Long Term Liabilities: AKSHARCHEM's short term assets (₹1.3B) exceed its long term liabilities (₹395.9M).
Debt to Equity History and Analysis
Debt Level: AKSHARCHEM's net debt to equity ratio (24.9%) is considered satisfactory.
Reducing Debt: AKSHARCHEM's debt to equity ratio has increased from 0% to 26.1% over the past 5 years.
Debt Coverage: AKSHARCHEM's debt is not well covered by operating cash flow (2.8%).
Interest Coverage: AKSHARCHEM's interest payments on its debt are not well covered by EBIT (1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/14 07:32 |
| End of Day Share Price | 2025/01/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AksharChem (India) Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vijay Madunala | FirstCall Research |
| Ankit Gor | Systematix Shares & Stocks (I) Ltd. |